|
|
Removal of Vioxx Shifts Drug Landscape
New York Times - Dec 1, 2004
The data released by IMS were for total prescriptions, including continuing ... Prescription versions of naproxen and ibuprofen have also gained some share. ...
|
|
Time for self-regulation of drug giants to end?
Pay-Per-View - National Business Review - Factiva, from Dow Jones - Nov 26, 2004
The trial had involved a comparison between an older NSAID (Naproxen) and Vioxx. ... so that data released after the launch of a drug is analysed for signs ...
|
|
Doctors, Too, Ask: Is This Drug Right?
New York Times - Dec 30, 2004
But after reviewing all relevant data, the Oregon group and others doing similar ... A study conducted by an FDA researcher that was released in September ...
|
|
|
FDA: Don't overdo pain pills
USA Today - Dec 26, 2004
If you think you need to take naproxen, ibuprofen or aspirin — all nonsteroidal ... according to a just-released health advisory from the FDA. ...
|
|
Merck Says New Pain Reliever Gentler
RedOrbit - Oct 19, 2004
Meanwhile, the other data released showed no increased risk when taking placebo, diclofenac or ibuprofen. When Arcoxia was compared to naproxen in the ...
|
|
|
Naproxen May Increase Risk of Heart Disease
Medscape - Dec 21, 2004
The US Food and Drug Administration (FDA) also released a statement Monday ... trial and continue with the naproxen group, because their data indicated that ...
|
|
